ADALIMUMAB SERUM DRUG LEVELS AND ANTI-DRUG ANTIBODIES: ASSOCIATION TO DISEASE ACTIVITY AND DRUG SURVIVAL IN INFLAMMATORY ARTHRITIS PATIENTS

被引：0
|
作者：
Jyssum, I. [1 ,2 ]
Gehin, J. E. [3 ]
Kristianslund, E. [1 ]
Sexton, J. [1 ]
Worren, D. [3 ]
Hu, Y. [4 ]
Kvien, T. K. [1 ]
Haavardsholm, E. A. [1 ,2 ]
Bolstad, N. [3 ]
Syversen, S. W. [1 ]
Goll, G. L. [1 ]
机构：
[1] Diakonhjemmet Hosp, Ctr treatment Rheumat & Musculoskeletal Dis REMED, Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Norwegian Radium Hosp, Dept Med Biochem, Oslo, Norway
[4] Lillehammer Hosp, Dept Rheumatol, Lillehammer, Norway
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Inflammatory arthritides; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.1369
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0345
引用
收藏
页码：421 / 422
页数：2
相关论文
共 50 条
  • [21] Response to vedolizumab therapy in patients with inflammatory bowel disease: Impact of drug levels, anti-drug antibodies and α4β7 target occupancy
    Ungar, B.
    Kopylov, U.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Lahat, A.
    Coscas, D.
    Waterman, M.
    Haj-Natour, O.
    Orbach-Zingboim, N.
    Mao, R.
    Chen, M.
    Chowers, Y.
    Eliakim, R.
    Ben-Horin, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S350 - S351
  • [22] Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure
    Kosmac, Miha
    Toplak, Natasa
    Simonini, Gabriele
    Pagnini, Ilaria
    Cimaz, Rolando
    Serbec, Vladka Curin
    Avcin, Tadej
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1099 - S1100
  • [23] ANTI-DRUG ANTIBODIES (ADA): ASSAY PERFORMANCE IN PATIENTS TREATED FOR INFLAMMATORY BOWEL AND RHEUMATIC DISEASE WITH BIODRUGS, ADALIMUMAB AND INFLIXIMAB
    O'Donnell, J.
    Liu, J.
    Keating, P.
    Hock, B.
    Spellerberg, M.
    Barclay, M.
    Stamp, L.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 15 - 15
  • [24] Drugs and anti-drug antibody levels in the management of patients with inflammatory bowel disease
    Lopez-Ibanez, Maria
    Marin-Jimenez, Ignacio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2016, 39 (04): : 265 - 272
  • [25] Factors that may influence the development of anti-drug antibodies to adalimumab
    Reinisch, W.
    Rauter, I.
    Chen, L.
    Gessner, M.
    Fanjiang, G.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S429 - S430
  • [26] Adalimumab/infliximabDevelopment of anti-drug antibodies: 7 case reports
    Reactions Weekly, 2018, 1701 (1) : 15 - 15
  • [27] UTILITY OF MEASURING ADALIMUMAB DRUG LEVELS AND ANTI-DRUG ANTIBODIES IN CLINICAL PRACTICE: A LARGE IBD REFERRAL CENTRE EXPERIENCE
    Warner, B. D.
    Johnston, E. L.
    Digby-Bell, J. L.
    Unsworth, N.
    Anderson, S.
    Sanderson, J. D.
    Arkir, Z.
    Irving, P. M.
    GUT, 2015, 64 : A93 - A93
  • [28] Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease
    Ha, Christina
    Mathur, Jagrati
    Kornbluth, Asher
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (04) : 497 - 505
  • [29] LOW DRUG CONCENTRATIONS AND ANTI-DRUG ANTIBODY FORMATION TO THE PRIOR ANTI-TNF PREDISPOSES PATIENTS WITH INFLAMMATORY BOWEL DISEASE TO DEVELOP ANTI-DRUG ANTIBODIES TO THE SUBSEQUENT ANTI-TNF
    Cheifetz, Adam S.
    Abreu, Maria T.
    Flier, Sarah N.
    Papamichail, Konstantinos
    Rieder, Florian
    Silverberg, Mark S.
    Khanna, Reena
    Okada, Lauren
    Yang, Lei
    Jain, Anjali
    Vande Casteele, Niels
    GASTROENTEROLOGY, 2020, 158 (06) : S457 - S457
  • [30] Association of drug-serum protein adducts and anti-drug antibodies in dogs with sulfonamide hypersensitivity.
    Lavergne, S. N.
    Volkman, E.
    Danhof, R.
    Trepanier, L. A.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2006, 20 (03) : 715 - 715
12345